- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2010
- Public Summary Document (PSD) July 2010 PBAC Meeting - PDF
Pazopanib – July 2010
PAZOPANIB, tablets, 200 mg and 400 mg (as hydrochloride), Votrient®, July 2010
Last updated
22 October 2010